Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELTROMBOPAG: 5,473 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
5,473
Total FAERS Reports
1,434 (26.2%)
Deaths Reported
2,066
Hospitalizations
5,473
As Primary/Secondary Suspect
432
Life-Threatening
96
Disabilities
None
Status

FDA Application: 208815 ·

First Report: 199901 · Latest Report: 20250924

What Are the Most Common ELTROMBOPAG Side Effects?

#1 Most Reported
Platelet count decreased
968 reports (17.7%)
#2 Most Reported
Death
629 reports (11.5%)
#3 Most Reported
Drug ineffective
554 reports (10.1%)

All ELTROMBOPAG Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Platelet count decreased 968 17.7% 148 545
Death 629 11.5% 629 80
Drug ineffective 554 10.1% 86 201
Product use in unapproved indication 303 5.5% 70 69
Thrombocytopenia 262 4.8% 33 112
Off label use 255 4.7% 50 87
Headache 229 4.2% 27 125
Pyrexia 229 4.2% 45 163
Haemoglobin decreased 213 3.9% 41 117
Pneumonia 204 3.7% 86 124
Platelet count increased 186 3.4% 24 101
Haemorrhage 173 3.2% 35 80
Therapy non-responder 166 3.0% 39 42
Malaise 154 2.8% 31 116
Anaemia 146 2.7% 28 53
Sepsis 143 2.6% 100 65
Fatigue 142 2.6% 20 65
Pulmonary embolism 138 2.5% 22 89
Diarrhoea 135 2.5% 21 72
Aplastic anaemia 131 2.4% 56 45

Who Reports ELTROMBOPAG Side Effects? Age & Gender Data

Gender: 53.5% female, 46.5% male. Average age: 55.3 years. Most reports from: JP. View detailed demographics →

Is ELTROMBOPAG Getting Safer? Reports by Year

YearReportsDeathsHosp.
2004 1 1 0
2007 1 0 1
2008 1 0 1
2009 2 0 1
2010 8 2 3
2011 61 19 24
2012 65 8 36
2013 95 19 49
2014 187 40 127
2015 362 73 232
2016 249 54 150
2017 308 94 160
2018 436 131 185
2019 426 159 192
2020 329 156 134
2021 54 14 29
2022 33 4 15
2023 34 1 12
2024 35 1 20
2025 16 1 12

View full timeline →

What Is ELTROMBOPAG Used For?

IndicationReports
Immune thrombocytopenic purpura 1,734
Aplastic anaemia 1,121
Immune thrombocytopenia 792
Product used for unknown indication 612
Thrombocytopenia 531
Myelodysplastic syndrome 246
Thrombocytopenic purpura 117
Platelet count decreased 57
Bone marrow failure 52
Acute myeloid leukaemia 40

ELTROMBOPAG vs Alternatives: Which Is Safer?

ELTROMBOPAG vs ELTROMBOPAG OLAMINE ELTROMBOPAG vs ELUXADOLINE ELTROMBOPAG vs ELVITEGRAVIR ELTROMBOPAG vs EMAPALUMAB ELTROMBOPAG vs EMAPALUMAB-LZSG ELTROMBOPAG vs EMEND ELTROMBOPAG vs EMICIZUMAB ELTROMBOPAG vs EMICIZUMAB-KXWH ELTROMBOPAG vs EMPAGLIFLOZIN ELTROMBOPAG vs EMPAGLIFLOZIN\LINAGLIPTIN

Official FDA Label for ELTROMBOPAG

Official prescribing information from the FDA-approved drug label.